title: Reply to "Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?".
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Brown
authors.forename: Nagham
authors.initials: N
authors.lastname: Khanafer
authors.forename: Nick
authors.initials: N
authors.lastname: Daneman
authors.forename: David N
authors.initials: DN
authors.lastname: Fisman
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D016360:Clostridioides difficile / Q000187:drug effects*; D017714:Community-Acquired Infections / Q000209:etiology*; D004761:Enterocolitis, Pseudomembranous / Q000209:etiology*; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents